On the 4th, GSK Korea announced it appointed Maurizio Borgatta, former General Manager of GSK Portugal as its new general manager.

After joining GSK in 2015, the new GM is known to have successfully launched and sold GSK’s treatments and vaccines in the European region, including Belgium, Spain, Italy, and the UK. Also, he contributed to increasing patient access to treatments in various countries including the United States, Japan, and Germany by launching a treatment for severe eosinophilic asthma and expanding indications.

Since 2021, he served as general manager of GSK Portugal, where he successfully achieved the expansion of indications for 8 innovative drugs and enabled the market